<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Your-Story.org &#187; Biotech</title>
	<atom:link href="http://your-story.org/category/science-technology/biotech/feed/" rel="self" type="application/rss+xml" />
	<link>http://your-story.org</link>
	<description>The Press Release Resource</description>
	<lastBuildDate>Fri, 25 May 2012 12:28:15 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>CelKine, a New Brand of GenScript, Focusing on Cytokine Research</title>
		<link>http://your-story.org/celkine-a-new-brand-of-genscript-focusing-on-cytokine-research-328017/</link>
		<comments>http://your-story.org/celkine-a-new-brand-of-genscript-focusing-on-cytokine-research-328017/#comments</comments>
		<pubDate>Thu, 03 May 2012 08:54:21 +0000</pubDate>
		<dc:creator>blueoxygen</dc:creator>
				<category><![CDATA[Biotech]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=328017</guid>
		<description><![CDATA[ May 1 , 2012 PISCATAWAY, New Jersey, 1st May, 2011 –GenScript USA Incorporation has announced the launch of one new brand, CelKine™ to offer cytokine related products and businesses. This brand will have its own new website. Cytokines are an important group of signaling proteins that carry signals between cells, tissues, and body parts, and ...]]></description>
		<wfw:commentRss>http://your-story.org/celkine-a-new-brand-of-genscript-focusing-on-cytokine-research-328017/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage (STO: BIOT) unveils Isolera Spektra with full PDA Spectral Scanning</title>
		<link>http://your-story.org/biotage-sto-biotunveils-isolera-spektra-with-full-pda-spectral-scanning-2-323954/</link>
		<comments>http://your-story.org/biotage-sto-biotunveils-isolera-spektra-with-full-pda-spectral-scanning-2-323954/#comments</comments>
		<pubDate>Thu, 12 Apr 2012 21:03:47 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[flash purification]]></category>
		<category><![CDATA[isolera spektra]]></category>
		<category><![CDATA[pda spectral scanning]]></category>
		<category><![CDATA[spectral scanning]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=323954</guid>
		<description><![CDATA[Biotage, a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced Isolera™ Spektra. Uppsala, Sweden, April 12, 2012 &#8212; Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced Isolera™ Spektra. The new Isolera™ Spektra expands the scope of application of Biotage’s market-leading Flash ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-sto-biotunveils-isolera-spektra-with-full-pda-spectral-scanning-2-323954/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ReactIR 247 Certified for Class 1, Division 1 Hazardous Use</title>
		<link>http://your-story.org/reactir-247-certified-for-class-1-division-1-hazardous-use-321004/</link>
		<comments>http://your-story.org/reactir-247-certified-for-class-1-division-1-hazardous-use-321004/#comments</comments>
		<pubDate>Fri, 30 Mar 2012 09:23:13 +0000</pubDate>
		<dc:creator>Marie-Louise Hupert</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[ATEX Directive]]></category>
		<category><![CDATA[Ex Certification for Zone 1]]></category>
		<category><![CDATA[Fourier Transform Infrared]]></category>
		<category><![CDATA[FTIR]]></category>
		<category><![CDATA[Groups IIB + H2]]></category>
		<category><![CDATA[hazardous manufacturing environments]]></category>
		<category><![CDATA[reduce testing costs]]></category>
		<category><![CDATA[speed time-to-market]]></category>
		<category><![CDATA[streamline production]]></category>
		<category><![CDATA[t4]]></category>
		<category><![CDATA[Zone 1]]></category>
		<category><![CDATA[Zone 1 Hazardous Environments]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=321004</guid>
		<description><![CDATA[The METTER TOLEDO ReactIR 247 HL-UL and related auxiliary items certified for safe use in North American Class I, Division 1 hazardous manufacturing environments are ready for immediate order. METTLER TOLEDO announced today that the ReactIR 247 has been certified for safe use in Class I, Division 1 hazardous manufacturing environments and is ready for ...]]></description>
		<wfw:commentRss>http://your-story.org/reactir-247-certified-for-class-1-division-1-hazardous-use-321004/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mettler-Toledo Thornton Releases Video to Assist Pharmaceutical Manufacturers in Monitoring and Controlling Water Use</title>
		<link>http://your-story.org/mettler-toledo-thornton-releases-video-to-assist-pharmaceutical-manufacturers-in-monitoring-and-controlling-water-use-316941/</link>
		<comments>http://your-story.org/mettler-toledo-thornton-releases-video-to-assist-pharmaceutical-manufacturers-in-monitoring-and-controlling-water-use-316941/#comments</comments>
		<pubDate>Wed, 14 Mar 2012 14:10:02 +0000</pubDate>
		<dc:creator>Marie-Louise Hupert</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[continuous on-line measurement solutions]]></category>
		<category><![CDATA[continuous real-time testing]]></category>
		<category><![CDATA[control water]]></category>
		<category><![CDATA[critical conductivity]]></category>
		<category><![CDATA[monitor water]]></category>
		<category><![CDATA[organic carbon]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=316941</guid>
		<description><![CDATA[Mettler-Toledo&#8217;s Process Analytics Division announces the release of &#8220;TOC and Conductivity Measurement in Water for Pharmaceutical Manufacturing,&#8221;a five-minute video describingthe continuous on-line measurement solutions which enable pharmaceutical manufacturers to continuously monitor and control water used in the manufacturing process. In pharmaceutical manufacturing, continuous real-time testing for total organic carbon and conductivity is critical to meet ...]]></description>
		<wfw:commentRss>http://your-story.org/mettler-toledo-thornton-releases-video-to-assist-pharmaceutical-manufacturers-in-monitoring-and-controlling-water-use-316941/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BrainStorm Cell Therapeutics Expands Pipeline with the Initiation of a Study for Multiple Sclerosis</title>
		<link>http://your-story.org/brainstorm-cell-therapeutics-expands-pipeline-with-the-initiation-of-a-study-for-multiple-sclerosis-315715/</link>
		<comments>http://your-story.org/brainstorm-cell-therapeutics-expands-pipeline-with-the-initiation-of-a-study-for-multiple-sclerosis-315715/#comments</comments>
		<pubDate>Tue, 13 Mar 2012 08:55:43 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[brainstorm]]></category>
		<category><![CDATA[brainstorm cell therapeutics]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[nurown]]></category>
		<category><![CDATA[stem cell technology]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=315715</guid>
		<description><![CDATA[Proposed Trial Will Build on NurOwn(TM) Platform to Meet Unmet Needs of Patients with Neurodegenerative Disorders. NEW YORK &#38; PETACH TIKVAH, ISRAEL, Mar 13, 2012 &#8212; BrainStorm Cell Therapeutics Inc., a developer of adult stem cell technologies and CNS therapeutics, announces plans to initiate a preclinical study assessing the efficacy of its NurOwn(TM) stem cell ...]]></description>
		<wfw:commentRss>http://your-story.org/brainstorm-cell-therapeutics-expands-pipeline-with-the-initiation-of-a-study-for-multiple-sclerosis-315715/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Innova Biosciences Launches Unique Covalent Gold Nanoparticle Conjugation Kit</title>
		<link>http://your-story.org/innova-biosciences-launches-unique-covalent-gold-nanoparticle-conjugation-kit-310265/</link>
		<comments>http://your-story.org/innova-biosciences-launches-unique-covalent-gold-nanoparticle-conjugation-kit-310265/#comments</comments>
		<pubDate>Tue, 21 Feb 2012 09:02:17 +0000</pubDate>
		<dc:creator>straightlinepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Biosciences]]></category>
		<category><![CDATA[Conjugation Kit]]></category>
		<category><![CDATA[Covalent Gold]]></category>
		<category><![CDATA[Innova Biosciences]]></category>
		<category><![CDATA[InnovaCoat]]></category>
		<category><![CDATA[Nanoparticle]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=310265</guid>
		<description><![CDATA[Innova Biosciences, inventor of ‘Lightning-Link®’ the world’s easiest to use antibody labeling technology, is pleased to announce the launch of InnovaCoat™ GOLD: a revolutionary kit for the covalent conjugation of gold nanoparticles to antibodies, proteins and biomolecules. Cambridge, UK, February 20, 2012 &#8211; Innova Biosciences (Cambridge, UK), inventor of ‘Lightning-Link®’ the world’s easiest to use ...]]></description>
		<wfw:commentRss>http://your-story.org/innova-biosciences-launches-unique-covalent-gold-nanoparticle-conjugation-kit-310265/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage (STO: BIOT) Introduces SNAP Ultra High Performance Flash Chromatography Cartridges with Biotage HP-Sphere Silica</title>
		<link>http://your-story.org/biotage-sto-biot-introduces-snap-ultra-high-performance-flash-chromatography-cartridges-with-biotage-hp-sphere-silica-308811/</link>
		<comments>http://your-story.org/biotage-sto-biot-introduces-snap-ultra-high-performance-flash-chromatography-cartridges-with-biotage-hp-sphere-silica-308811/#comments</comments>
		<pubDate>Tue, 14 Feb 2012 21:17:40 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[cartridges]]></category>
		<category><![CDATA[flash chromatography cartridges]]></category>
		<category><![CDATA[silica]]></category>
		<category><![CDATA[snap ultra]]></category>
		<category><![CDATA[STO: BIOT]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=308811</guid>
		<description><![CDATA[Biotage introduced the new Biotage® SNAP Ultra high performance flash chromatography cartridges utilizing Biotage® HP-Sphere™ spherical silica. Uppsala, Sweden, February 14, 2012 &#8212; Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced the new Biotage® SNAP Ultra high performance flash chromatography cartridges utilizing Biotage® HP-Sphere™ spherical silica. ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-sto-biot-introduces-snap-ultra-high-performance-flash-chromatography-cartridges-with-biotage-hp-sphere-silica-308811/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech stocks News; BioSante Pharmaceuticals (NasdaqGM: BPAX) Reports Positive LibiGel® Safety Data Review for Phase III Program</title>
		<link>http://your-story.org/biotech-stocks-news-biosante-pharmaceuticals-nasdaqgm-bpax-reports-positive-libigel-safety-data-review-for-phase-iii-program-307783/</link>
		<comments>http://your-story.org/biotech-stocks-news-biosante-pharmaceuticals-nasdaqgm-bpax-reports-positive-libigel-safety-data-review-for-phase-iii-program-307783/#comments</comments>
		<pubDate>Fri, 10 Feb 2012 08:26:27 +0000</pubDate>
		<dc:creator>Investorideas</dc:creator>
				<category><![CDATA[Biotech]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=307783</guid>
		<description><![CDATA[LINCOLNSHIRE, Ill. &#8211; February 9, 2012 (Investorideas.com Newswire) BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study ...]]></description>
		<wfw:commentRss>http://your-story.org/biotech-stocks-news-biosante-pharmaceuticals-nasdaqgm-bpax-reports-positive-libigel-safety-data-review-for-phase-iii-program-307783/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech Stock on the Move: BioSante (NasdaqGM: BPAX) Trades up over 37%</title>
		<link>http://your-story.org/biotech-stock-on-the-move-biosante-nasdaqgm-bpax-trades-up-over-37-306735/</link>
		<comments>http://your-story.org/biotech-stock-on-the-move-biosante-nasdaqgm-bpax-trades-up-over-37-306735/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 21:13:05 +0000</pubDate>
		<dc:creator>Investorideas</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[stocks]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=306735</guid>
		<description><![CDATA[New York, New York – February 6, 2012 &#8211; Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for BioSante Pharmaceuticals, Inc. (NasdaqGM: BPAX), trading up at $1.0199, gaining 0.2799 (37.82%) 3:10PM EST. The Company has rebounded from its low of $0.38, now trading above $1.00 ...]]></description>
		<wfw:commentRss>http://your-story.org/biotech-stock-on-the-move-biosante-nasdaqgm-bpax-trades-up-over-37-306735/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech Stock to Watch: Complete Genomics (Nasdaq:GNOM) Trades up over 15%</title>
		<link>http://your-story.org/biotech-stock-to-watch-complete-genomics-nasdaqgnom-trades-up-over-15-306716/</link>
		<comments>http://your-story.org/biotech-stock-to-watch-complete-genomics-nasdaqgnom-trades-up-over-15-306716/#comments</comments>
		<pubDate>Mon, 06 Feb 2012 17:28:47 +0000</pubDate>
		<dc:creator>Investorideas</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[stocks]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=306716</guid>
		<description><![CDATA[New York, New York &#8211; February 6, 2012 &#8211; Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues a trading alert for Complete Genomics Inc. (Nasdaq:GNOM). The stock is trading up at $3.46, gaining 0.45 (14.95%) 11:03AM EST on over 1.7 Million shares. Investorideas.com Newswire About Complete Genomics (Nasdaq:GNOM) ...]]></description>
		<wfw:commentRss>http://your-story.org/biotech-stock-to-watch-complete-genomics-nasdaqgnom-trades-up-over-15-306716/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation</title>
		<link>http://your-story.org/biotage-releases-new-catalog-and-technical-guide-for-sample-preparation-and-evaporation-304119/</link>
		<comments>http://your-story.org/biotage-releases-new-catalog-and-technical-guide-for-sample-preparation-and-evaporation-304119/#comments</comments>
		<pubDate>Sat, 28 Jan 2012 08:55:34 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[2012 catalog]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[Catalog]]></category>
		<category><![CDATA[new catalog]]></category>
		<category><![CDATA[sample preparation]]></category>
		<category><![CDATA[technical guide]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=304119</guid>
		<description><![CDATA[Biotage® introduced their 2012 catalog of analytical sample preparation products for chemistry professionals. Uppsala, Sweden, January 28, 2012 &#8212; Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, introduced their 2012 catalog of analytical sample preparation products for chemistry professionals. The significantly enhanced 200 page edition includes a ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-releases-new-catalog-and-technical-guide-for-sample-preparation-and-evaporation-304119/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GenScript Launches Rush Gene Synthesis Service</title>
		<link>http://your-story.org/genscript-launches-rush-gene-synthesis-service-295992/</link>
		<comments>http://your-story.org/genscript-launches-rush-gene-synthesis-service-295992/#comments</comments>
		<pubDate>Tue, 27 Dec 2011 21:51:00 +0000</pubDate>
		<dc:creator>blueoxygen</dc:creator>
				<category><![CDATA[Biotech]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=295992</guid>
		<description><![CDATA[PISCATAWAY, N.J., Dec 22, 2011 &#8211; Internationally recognized biology contract research organization GenScript USA Inc. today announced the launch of Rush Gene Synthesis service in global market. As the largest gene synthesis supplier worldwide, GenScript is dedicated to improve the quality and speed of gene synthesis by developing and applying innovative technologies. With the Rush ...]]></description>
		<wfw:commentRss>http://your-story.org/genscript-launches-rush-gene-synthesis-service-295992/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech Investor Alert for (OTC: AEMD), (Nasdaq:VRUS), (VRTX); Hepatitis C Virus (HCV) Treatments</title>
		<link>http://your-story.org/biotech-investor-alert-for-otc-aemd-nasdaqvrus-vrtx-hepatitis-c-virus-hcv-treatments-288961/</link>
		<comments>http://your-story.org/biotech-investor-alert-for-otc-aemd-nasdaqvrus-vrtx-hepatitis-c-virus-hcv-treatments-288961/#comments</comments>
		<pubDate>Mon, 28 Nov 2011 15:35:47 +0000</pubDate>
		<dc:creator>Investorideas</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[investments]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[stocks]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=288961</guid>
		<description><![CDATA[POINT ROBERTS &#8211; November 28, 2011 &#8211; www.InvestorIdeas.com issues a biotech investor alert for Pharmasset, Inc. (Nasdaq:VRUS), Vertex Pharmaceuticals (VRTX) and Aethlon Medical, Inc. (OTCBB: AEMD), three stocks involved in the treatment of Hepatitis C Virus (HCV). &#160; Over 170 million people worldwide are chronically infected with Hepatitis C. The sector made headlines earlier this ...]]></description>
		<wfw:commentRss>http://your-story.org/biotech-investor-alert-for-otc-aemd-nasdaqvrus-vrtx-hepatitis-c-virus-hcv-treatments-288961/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Introduces First Value-Priced, Full-Featured Flash Purification System</title>
		<link>http://your-story.org/biotage-introduces-first-value-priced-full-featured-flash-purification-system-284432/</link>
		<comments>http://your-story.org/biotage-introduces-first-value-priced-full-featured-flash-purification-system-284432/#comments</comments>
		<pubDate>Thu, 10 Nov 2011 23:02:50 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[biotage zip]]></category>
		<category><![CDATA[flash cartridges]]></category>
		<category><![CDATA[flash purification system]]></category>
		<category><![CDATA[isolera prime]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=284432</guid>
		<description><![CDATA[Biotage® (STO: BIOT), a leading manufacturer of tools and technology for medicinal, organic, and analytical chemistry, introduced the new Isolera PrimeTM flash purification system. Uppsala, Sweden &#8211; November 10, 2011 &#8212; Biotage® (STO: BIOT), a leading manufacturer of tools and technology for medicinal, organic, and analytical chemistry, introduced the new Isolera PrimeTM flash purification system. ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-introduces-first-value-priced-full-featured-flash-purification-system-284432/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PREMIER Biosoft Releases SimGlycan® 3.50 with Support for Multiple Adducts.</title>
		<link>http://your-story.org/premier-biosoft-releases-simglycan%c2%ae-3-50-with-support-for-multiple-adducts-283816/</link>
		<comments>http://your-story.org/premier-biosoft-releases-simglycan%c2%ae-3-50-with-support-for-multiple-adducts-283816/#comments</comments>
		<pubDate>Wed, 09 Nov 2011 09:45:48 +0000</pubDate>
		<dc:creator>Neilwatson</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[MS data analysis tool]]></category>
		<category><![CDATA[PREMIER Biosoft]]></category>
		<category><![CDATA[Structural elucidation of glycans]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=283816</guid>
		<description><![CDATA[Palo Alto, California – 9 November, 2011, PREMIER Biosoft today announced the release of a new version of SimGlycan®, its comprehensive, high throughput multi-stage MS data analysis tool. The program now includes support for adducts such as Li and K. Additionally, SimGlycan® 3.50 enables users to analyze MSn profiles using adduct combinations such as Na ...]]></description>
		<wfw:commentRss>http://your-story.org/premier-biosoft-releases-simglycan%c2%ae-3-50-with-support-for-multiple-adducts-283816/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Introduces Automated SPE Workstation for Increasing Productivity in Sample Preparation</title>
		<link>http://your-story.org/biotage-introduces-automated-spe-workstation-for-increasing-productivity-in-sample-preparation-278905/</link>
		<comments>http://your-story.org/biotage-introduces-automated-spe-workstation-for-increasing-productivity-in-sample-preparation-278905/#comments</comments>
		<pubDate>Wed, 19 Oct 2011 18:49:43 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[rapidtrace]]></category>
		<category><![CDATA[sample preparation]]></category>
		<category><![CDATA[spe workstation]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=278905</guid>
		<description><![CDATA[Biotage&#174; introduced the new RapidTrace&#174;+ SPE Workstation. RapidTrace+ is based on the widely accepted, industry standard RapidTrace platform. Uppsala, Sweden &#8211; October 18, 2011 &#8212; Biotage&#174; (STO: BIOT), a leading manufacturer of tools and technology for analytical and medicinal chemistry, introduced the new RapidTrace&#174;+ SPE Workstation. RapidTrace+ is based on the widely accepted, industry standard ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-introduces-automated-spe-workstation-for-increasing-productivity-in-sample-preparation-278905/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GenScript sued GeneWiz for unfair competition</title>
		<link>http://your-story.org/genscript-sued-genewiz-for-unfair-competition-277312/</link>
		<comments>http://your-story.org/genscript-sued-genewiz-for-unfair-competition-277312/#comments</comments>
		<pubDate>Thu, 13 Oct 2011 20:24:21 +0000</pubDate>
		<dc:creator>blueoxygen</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[gene synthesis]]></category>
		<category><![CDATA[GeneWiz]]></category>
		<category><![CDATA[GenScript]]></category>
		<category><![CDATA[trade secret]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=277312</guid>
		<description><![CDATA[PISCATAWAY, N.J., Sep 15, 2011 &#8211; GenScript USA, Inc. filed in New Jersey court a law suit against GeneWiz Inc. for misappropriation of trade secret and unfair competition. GenScript will seek compensatory damages, permanent injunctions, and other remedies from GeneWiz. &#160; GenScript USA, Inc. is a leading contract research organization (CRO) specialized in biological research ...]]></description>
		<wfw:commentRss>http://your-story.org/genscript-sued-genewiz-for-unfair-competition-277312/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSHL Team Finds Evidence For The Genetic Basis Of Autism</title>
		<link>http://your-story.org/cshl-team-finds-evidence-for-the-genetic-basis-of-autism-276764/</link>
		<comments>http://your-story.org/cshl-team-finds-evidence-for-the-genetic-basis-of-autism-276764/#comments</comments>
		<pubDate>Wed, 12 Oct 2011 15:30:31 +0000</pubDate>
		<dc:creator>pressreleasesolutions</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[Autism]]></category>
		<category><![CDATA[chromosome engineering]]></category>
		<category><![CDATA[Genetic Basis Of Autism]]></category>
		<category><![CDATA[Models of autism]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=276764</guid>
		<description><![CDATA[Models of autism show that gene copy number controls brain structure and behavior. Cold Spring Harbor, N.Y &#8211; October 12, 2011 &#8212; Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered that one of the most common genetic alterations in autism—deletion of a 27-gene cluster on chromosome 16—causes autism-like features. By generating mouse models of ...]]></description>
		<wfw:commentRss>http://your-story.org/cshl-team-finds-evidence-for-the-genetic-basis-of-autism-276764/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020</title>
		<link>http://your-story.org/engineering-next-generation-therapeutic-proteins-trends-and-markets-to-2020-263437/</link>
		<comments>http://your-story.org/engineering-next-generation-therapeutic-proteins-trends-and-markets-to-2020-263437/#comments</comments>
		<pubDate>Sat, 27 Aug 2011 14:05:29 +0000</pubDate>
		<dc:creator>InsightPharmaReports</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Antibodies]]></category>
		<category><![CDATA[biological drugs]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[market reports]]></category>
		<category><![CDATA[Market Research]]></category>
		<category><![CDATA[monoclonal antibodies]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[protein engineering]]></category>
		<category><![CDATA[proteins]]></category>
		<category><![CDATA[Therapeutic Proteins]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=263437</guid>
		<description><![CDATA[NEEDHAM, MASS. – August 26, 2011 – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report, Authored by Hermann Mucke, PhD. By 2020, the current renaissance of biotechnology will have resulted in a broad range of products that will, almost without exception, involve a degree of ...]]></description>
		<wfw:commentRss>http://your-story.org/engineering-next-generation-therapeutic-proteins-trends-and-markets-to-2020-263437/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insight Pharma Reports Announces: Next Generation Sequencing Generates Momentum</title>
		<link>http://your-story.org/insight-pharma-reports-announces-next-generation-sequencing-generates-momentum-263436/</link>
		<comments>http://your-story.org/insight-pharma-reports-announces-next-generation-sequencing-generates-momentum-263436/#comments</comments>
		<pubDate>Sat, 27 Aug 2011 14:05:17 +0000</pubDate>
		<dc:creator>InsightPharmaReports</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[bioinformatics]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[market reports]]></category>
		<category><![CDATA[Market Research]]></category>
		<category><![CDATA[next generation sequencing]]></category>
		<category><![CDATA[NGS]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[sequencing]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=263436</guid>
		<description><![CDATA[NEEDHAM, MASS. – August 26, 2011 – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Next Generation Sequencing Generates Momentum: Markets Respond to Technology and Innovation Advances Report, Authored by Ken Rubenstein, PhD. This report focuses on current and innovative NGS technologies, services and markets to answer such questions as; •Which early NGS market entrants ...]]></description>
		<wfw:commentRss>http://your-story.org/insight-pharma-reports-announces-next-generation-sequencing-generates-momentum-263436/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Portal Gives Investors Carbon Market Insights</title>
		<link>http://your-story.org/new-portal-gives-investors-carbon-market-insights-259959/</link>
		<comments>http://your-story.org/new-portal-gives-investors-carbon-market-insights-259959/#comments</comments>
		<pubDate>Fri, 12 Aug 2011 09:17:19 +0000</pubDate>
		<dc:creator>smartebusiness1</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[carbon]]></category>
		<category><![CDATA[global carbon market]]></category>
		<category><![CDATA[market]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=259959</guid>
		<description><![CDATA[LONDON (August 9, 2011) &#8211; Invezz, one of UK&#8217;s up-and-coming boutique digital media companies, introduced today theirnewly launchedinvestments information portal, Carbon Markets (www.carbon-markets.co.uk). The website is designed to provide large corporations, small businesses and environmentally conscious individuals with valuable insights on the state, trends and forecasts of the dynamic carbon markets. &#8220;Carbon investments havebeen slowly ...]]></description>
		<wfw:commentRss>http://your-story.org/new-portal-gives-investors-carbon-market-insights-259959/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Online Educational Webinar to Explain Systolic and Diastolic Function in Rodent Models of Metabolic Syndrome</title>
		<link>http://your-story.org/online-educational-webinar-to-explain-systolic-and-diastolic-function-in-rodent-models-of-metabolic-syndrome-253971/</link>
		<comments>http://your-story.org/online-educational-webinar-to-explain-systolic-and-diastolic-function-in-rodent-models-of-metabolic-syndrome-253971/#comments</comments>
		<pubDate>Tue, 19 Jul 2011 14:15:58 +0000</pubDate>
		<dc:creator>scisense</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Adinstruments]]></category>
		<category><![CDATA[cardiac contractility]]></category>
		<category><![CDATA[cardiac function]]></category>
		<category><![CDATA[millar]]></category>
		<category><![CDATA[pressure-volume]]></category>
		<category><![CDATA[pressure-volume loop]]></category>
		<category><![CDATA[solid state pressure sensor]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=253971</guid>
		<description><![CDATA[For Immediate Release July, 18, 2011 &#8211; Scisense Systems Inc. hosts Dr. DeMarco from the University of Missouri. Dr. DeMarco will give an overview and summary of the PV loop data from transgenic Ren2 and Zucker obese rat models. Furthermore, he will review the results describing the cardiac dysfunction and address some of the technicalities ...]]></description>
		<wfw:commentRss>http://your-story.org/online-educational-webinar-to-explain-systolic-and-diastolic-function-in-rodent-models-of-metabolic-syndrome-253971/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Young mum is a science star</title>
		<link>http://your-story.org/young-mum-is-a-science-star-252875/</link>
		<comments>http://your-story.org/young-mum-is-a-science-star-252875/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 11:32:03 +0000</pubDate>
		<dc:creator>greg.russell</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[bioscience]]></category>
		<category><![CDATA[Edinburgh]]></category>
		<category><![CDATA[ewing]]></category>
		<category><![CDATA[midlothian]]></category>
		<category><![CDATA[roslin]]></category>
		<category><![CDATA[science]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=252875</guid>
		<description><![CDATA[A YOUNG mother, who always wanted to work in science but lacked the confidence to pursue her dream career, is now a rising star in a Midlothian company which is a world leader in stem cell technology, thanks to the Modern Apprenticeship scheme and her own hard work. Twenty-nine-year-old Emma Clarke had spent her working ...]]></description>
		<wfw:commentRss>http://your-story.org/young-mum-is-a-science-star-252875/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Introduces New Microwave Peptide Synthesizer Delivering</title>
		<link>http://your-story.org/biotage-introduces-new-microwave-peptide-synthesizer-delivering-252632/</link>
		<comments>http://your-story.org/biotage-introduces-new-microwave-peptide-synthesizer-delivering-252632/#comments</comments>
		<pubDate>Wed, 13 Jul 2011 12:06:19 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[microwave peptide synthesizer]]></category>
		<category><![CDATA[peptide professionals]]></category>
		<category><![CDATA[peptide synthesis]]></category>
		<category><![CDATA[peptides]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=252632</guid>
		<description><![CDATA[Biotage introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide Symposium in San Diego, California USA. Uppsala, Sweden, July 12, 2011 &#8212; Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, introduced an innovative, new instrument for peptide professionals at the 2011 American Peptide ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-introduces-new-microwave-peptide-synthesizer-delivering-252632/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Raises the Bar in Microwave Synthesis</title>
		<link>http://your-story.org/biotage-raises-the-bar-in-microwave-synthesis-251661/</link>
		<comments>http://your-story.org/biotage-raises-the-bar-in-microwave-synthesis-251661/#comments</comments>
		<pubDate>Fri, 08 Jul 2011 08:47:41 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[initiator+]]></category>
		<category><![CDATA[initiator+ synthesizer]]></category>
		<category><![CDATA[microwave synthesis]]></category>
		<category><![CDATA[microwave synthesizer]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=251661</guid>
		<description><![CDATA[Uppsala, Sweden, July 08, 2010 &#8212; Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical, medicinal, and peptide chemistry, announced a new microwave synthesizer with state of the art user interface and industry leading operating range. The Biotage Initiator+ sets a new standard by delivering new opportunities for chemistry professionals needing to ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-raises-the-bar-in-microwave-synthesis-251661/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Chemical Plants Become More Efficient with Help from Intelligent Sensors</title>
		<link>http://your-story.org/chemical-plants-become-more-efficient-with-help-from-intelligent-sensors-250733/</link>
		<comments>http://your-story.org/chemical-plants-become-more-efficient-with-help-from-intelligent-sensors-250733/#comments</comments>
		<pubDate>Mon, 04 Jul 2011 14:38:56 +0000</pubDate>
		<dc:creator>Marie-Louise Hupert</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA["Chemical Plants]]></category>
		<category><![CDATA[chemical industry]]></category>
		<category><![CDATA[conductivity]]></category>
		<category><![CDATA[DO]]></category>
		<category><![CDATA[downtime]]></category>
		<category><![CDATA[Intelligent Sensors]]></category>
		<category><![CDATA[measuring parameters"]]></category>
		<category><![CDATA[ORP]]></category>
		<category><![CDATA[pH]]></category>
		<category><![CDATA[substantial expenditure]]></category>
		<category><![CDATA[turbidity]]></category>

		<guid isPermaLink="false">http://your-story.org/?p=250733</guid>
		<description><![CDATA[A large variety of processes, few of which are exactly alike, typical unit operations share many commonalities. One of these is the requirement for accurate process analytics in order to help maximize product quality and yield and to minimize costs. Measurement of pH, ORP, conductivity, DO or turbidity may seem like small parts of a ...]]></description>
		<wfw:commentRss>http://your-story.org/chemical-plants-become-more-efficient-with-help-from-intelligent-sensors-250733/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Announces Peptide Research Collaboration with the Laboratory of Peptide and Protein Chemistry and Biology in Florence, Italy</title>
		<link>http://your-story.org/biotage-announces-peptide-research-collaboration-with-the-laboratory-of-peptide-and-protein-chemistry-and-biology-in-florence-italy-245757/</link>
		<comments>http://your-story.org/biotage-announces-peptide-research-collaboration-with-the-laboratory-of-peptide-and-protein-chemistry-and-biology-in-florence-italy-245757/#comments</comments>
		<pubDate>Thu, 02 Jun 2011 10:43:36 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[collaboration]]></category>
		<category><![CDATA[peptide production]]></category>
		<category><![CDATA[peptide research]]></category>
		<category><![CDATA[peptlab]]></category>
		<category><![CDATA[research agreement]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=245757</guid>
		<description><![CDATA[Biotage (STO: BIOT), announced a collaborative research agreement with The Laboratory of Peptide &#38; Protein Chemistry &#38; Biology (PeptLab) located in Florence, Italy. Uppsala, Sweden, June 01, 2011 &#8212; Biotage (STO: BIOT), a leading supplier of tools and technology for analytical and medicinapl chemistry, announced a collaborative research agreement with The Laboratory of Peptide &#38; ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-announces-peptide-research-collaboration-with-the-laboratory-of-peptide-and-protein-chemistry-and-biology-in-florence-italy-245757/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Insight Pharma Reports Announces Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report</title>
		<link>http://your-story.org/insight-pharma-reports-announces-commercializing-biomarkers-in-therapeutic-and-diagnostic-applications-report-245702/</link>
		<comments>http://your-story.org/insight-pharma-reports-announces-commercializing-biomarkers-in-therapeutic-and-diagnostic-applications-report-245702/#comments</comments>
		<pubDate>Wed, 01 Jun 2011 20:04:29 +0000</pubDate>
		<dc:creator>InsightPharmaReports</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Cardiology]]></category>
		<category><![CDATA[diagnostic markets]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[Market Research]]></category>
		<category><![CDATA[nerurology]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Reports]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=245702</guid>
		<description><![CDATA[For more information: Lisa Scimemi Insight Pharma Reports 781-972-5446  FOR IMMEDIATE RELEASE Insight Pharma Reports Announces Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report  NEEDHAM, MASS.  – Cambridge Healthtech Institute’s Insight Pharma Reports announces the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Report, Authored by Lucy Sannes, MBA, PhD. Biomarkers feature in thousands of published articles each ...]]></description>
		<wfw:commentRss>http://your-story.org/insight-pharma-reports-announces-commercializing-biomarkers-in-therapeutic-and-diagnostic-applications-report-245702/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Introduces New Positive Pressure, Solid Phase Extraction Platforms for Increasing Productivity in Sample Preparation</title>
		<link>http://your-story.org/biotage-introduces-new-positive-pressure-solid-phase-extraction-platforms-for-increasing-productivity-in-sample-preparation-244610/</link>
		<comments>http://your-story.org/biotage-introduces-new-positive-pressure-solid-phase-extraction-platforms-for-increasing-productivity-in-sample-preparation-244610/#comments</comments>
		<pubDate>Thu, 26 May 2011 10:26:27 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[analytes]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[extraction platforms]]></category>
		<category><![CDATA[pressure]]></category>
		<category><![CDATA[sample preparation]]></category>
		<category><![CDATA[solid phase extraction]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=244610</guid>
		<description><![CDATA[Uppsala, Sweden, May 26, 2011 &#8212; Biotage® (STO: BIOT), a leading supplier of tools and technology for analytical and medicinal chemistry, announced 2 new instruments that utilize positive pressure for solid-phase extraction (SPE) of analytes in a wide variety of applications. The Biotage PRESSURE+ 96 processes 96-well SPE plates and the Biotage PRESSURE+ 48 processes ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-introduces-new-positive-pressure-solid-phase-extraction-platforms-for-increasing-productivity-in-sample-preparation-244610/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotage Introduces EVOLUTE WAX, Providing a Total Solution for Acidic Compounds</title>
		<link>http://your-story.org/biotage-introduces-evolute-wax-providing-a-total-solution-for-acidic-compounds-238869/</link>
		<comments>http://your-story.org/biotage-introduces-evolute-wax-providing-a-total-solution-for-acidic-compounds-238869/#comments</comments>
		<pubDate>Thu, 21 Apr 2011 11:23:29 +0000</pubDate>
		<dc:creator>staronepr</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[acidic analytes]]></category>
		<category><![CDATA[acidic compounds]]></category>
		<category><![CDATA[biotage]]></category>
		<category><![CDATA[evolute wax]]></category>
		<category><![CDATA[sample preparation products]]></category>

		<guid isPermaLink="false">http://www.your-story.org/?p=238869</guid>
		<description><![CDATA[Uppsala, Sweden, April 20, 2011 &#8212; Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the further expansion of its successful family of sample preparation products with the launch of EVOLUTE WAX. EVOLUTE WAX is a mixed-mode weak anion exchanger, developed for the extraction of strongly acidic analytes from ...]]></description>
		<wfw:commentRss>http://your-story.org/biotage-introduces-evolute-wax-providing-a-total-solution-for-acidic-compounds-238869/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: your-story.org @ 2012-05-25 14:02:19 -->
